INTERACT: Reducing BP in ICH

In a multicenter open label pilot study published in Lancet Neurology investigators looked at safety and benefit of Intensive BP lowering in patients with ICH.

Methods:The patients, whose elevated systolic blood pressure ranged from 150 to 220 mm Hg, were randomly assigned to early intensive lowering of systolic BP to a target of 140 mm Hg or standard guideline-based management with a target of 180 mm Hg.

Concluson: Early intensive BP-lowering treatment is clinically feasible, well tolerated, and seems to reduce haematoma growth in ICH.